C. Carvalho-Wodarz

Modelling the bronchial barrier in pulmonary drug delivery: A human bronchial epithelial cell line supplemented with human tracheal mucus

C. Lehr, B. Loretz, U. Schaefer, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Decoding (patho-)physiology of the lung by advanced in vitro models for developing novel anti-infectives therapies.

C. Kloft, C. Lehr, C. Carvalho-Wodarz, 2020, Drug discovery today.

Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.

C. Prestidge, C. Lehr, C. Carvalho-Wodarz, 2021, Small.

Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility.

F. Nicotra, F. Re, C. Lehr, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Nanoencapsulation of a glucocorticoid improves barrier function and anti‐inflammatory effect on monolayers of pulmonary epithelial cell lines

C. Lehr, S. Guterres, A. Pohlmann, 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives.

R. Bals, C. Beisswenger, T. Ebensen, 2020, Journal of visualized experiments : JoVE.

Overview of Inhaled Nanopharmaceuticals.

C. Lehr, B. Loretz, X. Murgia, 2023, Journal of aerosol medicine and pulmonary drug delivery.

in pulmonary

C. Lehr, B. Loretz, U. Schaefer, 2021 .